Rahul Vedula

9PUBLICATIONS
99CO-AUTHORS
Molecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene expression (incl. microarray and other genome-wide approaches)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 30, 2026
A Phase Ib/II study of ceralasertib, a selective inhibitor of ATR, in patients with relapsed or refractory MDS and CMML.

|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and Decitabine.

|Feb 24, 2026
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse.

H Moses Murdock, Haesook T Kim, Katie Maurer

|Dec 17, 2025
Genomics of Acute Myeloid Leukemia at Diagnosis and Remission.

Kai Yu, Laura W Dillon, Jesse M Tettero

|Oct 31, 2025
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse.

H Moses Murdock, Haesook T Kim, Katie Maurer

|Jul 08, 2024
CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias.

Rahul S Vedula, Hannah Q Karp, Jeremy Koob

Pageof 2

Frequent Collaborators

6 joint publications

Jacqueline S Garcia

6 joint publications

Marlise R Luskin

5 joint publications

Eric S Winer

3 joint publications

Evan C Chen